For nearly 20 years, CutisPharma's singular focus has been to address the needs of patients who are unable to take capsules or tablets, such as children and the elderly, for whom no therapy is commercially available.
Richard Charpie is a Founder and Managing Partner at Ampersand Capital Partners. Richard has more than 30 years of private equity experience. He founded Ampersand Capital Partners in 1988 by leading its spinoff from PaineWebber. Richard has served as a Managing Partner of all of Ampersand’s funds. Having been a director of more than thirty-five companies and Chairman of more than ten, Richard’s board seats have included: CoreLabs, Confluent, Endeca, Talecris and TriPath. He holds an M.S. in Physics and a Ph.D. in Economics and Finance, both from MIT.